NCT05762965

Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women

Name: Clinical Trial NCT05762965
Creator: Wageningen University and Research
Keywords: Microbial Colonization, GOS 1, dietary supplement, clinical trial, Netherlands

Wageningen University and Research·ClinicalTrials.gov·dietary supplementRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Microbial Colonization
Drug/Device/Intervention: GOS 1
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Wageningen University and Research
Location: Wageningen, Netherlands

Timeline & enrollment

Phase: N/A
Start date: May 15, 2023
End date: Jul 08, 2023
Enrollment: 92 participants

Primary outcome

faecal abundance of Bifidobacterium,faecal abundance of Bifidobacterium,faecal abundance of Bifidobacterium

Summary

Within the Denali study the effect of 3 weeks intervention with GOS on the abundance of Bifidobacterium in faecal samples will be investigated.

ICD-10 classifications

Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05762965
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05762965 through Pure Global AI's free database. This phase not specified trial is sponsored by Wageningen University and Research and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 92 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.